Hormone Replacement Therapy

Lower-Dose Protects Against Osteoporosis And Alleviates Menopausal Symptoms

Published in Women's Health Weekly, December 20th, 2001

For the first time low-dose hormone replacement therapy (HRT) has been proven as effective as the current standard dose in preventing osteoporosis and treating menopausal symptoms in younger menopausal women (ages 45-56) as previously seen in women ages 65 and older.

Researchers at the University of Pisa, Italy found that at the end of two years, bone mass density (BMD) was significantly increased by nearly 3% in the women who took low-dose HRT. BMD actually decreased by 7.9% in the women who took calcium alone. This is relevant because BMD is a predictor for osteoporosis.

"Low-dose HRT will be a good option for newly menopausal women and their...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2001-12-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry